Abstract
Allogeneic hematopoietic stem cell transplantation (HSCT) is the only potentially curative treatment for the BM dysfunction seen in patients with Shwachman–Diamond syndrome (SDS). Historically, these patients have fared poorly with intensive conditioning regimens with increased regimen-related toxicity especially involving the heart and lungs. We report our institutional experience with a reduced-intensity-conditioning protocol in seven patients with SDS and BM aplasia or myelodysplastic syndrome/AML. The preparative regimen consisted of Campath-1H, fludarabine and melphalan. Four patients received matched related marrow and three received unrelated stem cells (two PBSCs and one marrow). All but one was 8 of 8 allele HLA matched. All patients established 100% donor-derived hematopoiesis. No patient in this cohort developed grades III–IV GVHD. One patient had grade II skin GVHD that responded to systemic corticosteroids and one had grade I skin GVHD, treated with topical corticosteroids. Two out of seven patients developed bacterial infections in the early post transplant period. Viral infections were seen in four out of seven patients and were successfully treated with appropriate antiviral therapy. All patients are currently alive. These data indicate that HSCT with reduced-intensity conditioning is feasible in patients with SDS and associated with excellent donor cell engraftment and modest morbidity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Shwachman H, Diamond L, Oski F, Khaw K . The syndrome of pancreatic insufficiency and bone marrow dysfunction. J Pediatr 1964; 65: 645–663.
Bodian M, Sheldon W, Lightwood R . Congenital hypoplasia of the exocrine pancreas. Acta Paediatr 1964; 53: 282–293.
Aggett PJ, Cavanagh NPC, Matthew DJ, Pincott JR, Sutcliffe J, Harries JT . Shwachman's syndrome: a review of 21 cases. Arch Dis Child 1980; 55: 331–347.
Ginzberg H, Shin J, Ellis L, Morrison J, Ip W, Dror Y et al. Shwachman syndrome: phenotypic manifestations of sibling sets and isolated cases in a large patient cohort are similar. J Pediatr 1999; 135: 81–88.
Berrocal T, Simón MJ, al-Assir I, Prieto C, Pastor I, de Pablo L et al. Shwachman–Diamond syndrome: clinical, radiological and sonographic aspects. Pediatr Radiol 1995; 25: 289–292.
Robberecht E, Nachtegaele P, Van Rattinghe R, Afschrift M, Kunnen M, Verhaaren R . Pancreatic lipomatosis in the Shwachman–Diamond syndrome. Identification by sonography and CT-scan. Pediatr Radiol 1985; 15: 348–349.
Mack DR, Forstner GG, Wilschanski M, Freedman MH, Durie PR . Shwachman syndrome: exocrine pancreatic dysfunction and variable phenotypic expression. Gastroenterology 1996; 111: 1593–1602.
Dror Y, Ginzberg H, Dalal I, Cherepanov V, Downey G, Durie P et al. Immune function in patients with Shwachman–Diamond syndrome. Br J Haematol 2001; 114: 712–717.
Huijgens P, van der Veen E, Meijer S, Muntinghe O . Syndrome of Shwachman and leukemia. Scand J Haematol 1977; 18: 20–24.
Smith OP, Hann IM, Chessells JM, Reeves BR, Milla P . Haematological abnormalities in Shwachman–Diamond syndrome. Br J Haematol 1996; 94: 279–284.
Dokal I, Rule S, Chen F, Potter M, Goldman J . Adult onset of acute myeloid leukaemia (M6) in patients with Shwachman–Diamond syndrome. Br J Haematol 1997; 99: 171–173.
Dror Y, Freedman MH . Malignant myeloid transformation with isochromosome 7q in Shwachman–Diamond syndrome. Leukemia 1998; 12: 1591–1595.
Donadieu J, Leblanc T, Bader Meunier B, Barkaoui M, Fenneteau O, Bertrand Y, et al., French Severe Chronic Neutropenia Study Group. Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group. Haematologica 2005; 90: 45–53.
Alter BP, Young NS . Shwachman Diamond syndrome. In: Nathan DG, Orkin SH (eds). Nathan and Oski's Hematology of Infancy and Childhood, 5th edn, vol 1 WB Saunders: Philadelphia, 1997, pp 276–278.
Tsai PH, Sahdev I, Herry A, Lipton JM . Fatal cyclophosphamide-induced congestive heart failure in a 10-year-old boy with Shwachman–Diamond syndrome and severe bone marrow failure treated with allogeneic bone marrow transplantation. Am J Pediatr Hematol Oncol 1990; 12: 472–476.
Okcu F, Roberts WM, Chan KW . Bone marrow transplantation in Shwachman–Diamond syndrome: report of two cases and review of the literature. Bone Marrow Transplant 1998; 21: 849–851.
Cesaro S, Oneto R, Messina C, Gibson BE, Buzyn A, Steward C, et al., EBMT Severe Aplastic Anaemia and Paediatric Diseases Working Party. Haematopoietic stem cell transplantation for Shwachman–Diamond disease: a study from the European Group for blood and marrow transplantation. Br J Haematol 2005; 131: 231–236.
Donadieu J, Michel G, Merlin E, Bordigoni P, Monteux B, Beaupain B et al. Hematopoietic stem cell transplantation for Shwachman–Diamond syndrome: experience of the French neutropenia registry. Bone Marrow Transplant 2005; 36: 787–792.
Barrios N, Kirkpatrick D, Regueira O, Wuttke B, McNeil J, Humbert J . Bone marrow transplant in Shwachman Diamond syndrome. Br J Haematol 1991; 79: 337–338.
Smith OP, Chan MY, Evans J, Veys P . Shwachman–Diamond syndrome and matched unrelated donor BMT. Bone Marrow Transplant 1995; 16: 717–718.
Arseniev L, Diedrich H, Link H . Allogeneic bone marrow transplantation in a patient with ShwachmanDiamond syndrome. Ann Hematol 1996; 72: 83–84.
Faber J, Lauener R, Wick F, Betts D, Filgueira L, Seger RA et al. Shwachman–Diamond syndrome: early bone marrow transplantation in a high risk patient and new clues to pathogenesis. Eur J Pediatr 1999; 158: 995–1000.
Fleitz J, Rumelhart S, Goldman F, Ambruso D, Sokol RJ, Pacini D et al. Successful allogeneic hematopoietic stem cell transplantation (HSCT) for Shwachman–Diamond syndrome. Bone Marrow Transplant 2002; 29: 75–79.
Cesaro S, Guariso G, Calore E, Gazzola MV, Destro R, Varotto S et al. Successful unrelated bone marrow transplantation for Shwachman–Diamond syndrome. Bone Marrow Transplant 2001; 27: 97–99.
Hsu JW, Vogelsang G, Jones RJ, Brodsky RA . Bone marrow transplantation in Shwachman–Diamond syndrome. Bone Marrow Transplant 2002; 30: 255–258.
Park SY, Chae MB, Kwack YG, Lee MH, Kim I, Kim YS et al. Allogeneic bone marrow transplantation in Shwachman–Diamond syndrome with malignant myeloid transformation. A case report. Korean J Intern Med 2002; 17: 204–206.
Cunningham J, Sales M, Pearce A, Howard J, Stallings R, Telford N et al. Does isochromosome 7q mandate bone marrow transplant in children with Shwachman–Diamond syndrome? Br J Haematol 2002; 119: 1062–1069.
Mitsui T, Kawakami T, Sendo D, Katsuura M, Shimizu Y, Hayasaka K . Successful unrelated donor bone marrow transplantation for Shwachman–Diamond syndrome with leukemia. Int J Hematol 2004; 79: 189–192.
Grewal SS, Barker JN, Davies SM, Wagner JE . Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood? Blood 2003; 101: 4233–4244. E-pub 9 January 2003.
Vibhakar R, Radhi M, Rumelhart S, Tatman D, Goldman F . Successful unrelated umbilical cord blood transplantation in children with Shwachman–Diamond syndrome. Bone Marrow Transplant 2005; 36: 855–861.
Savilahti E, Rapola J . Frequent myocardial lesions in Shwachman syndrome. Eight fatal cases among 16 Finnish patients. Acta Paediatr Scand 1984; 73: 642–651.
Ferry C, Ouachée M, Leblanc T, Michel G, Notz-Carrére A, Tabrizi R et al. Hematopoietic stem cell transplantation in severe congenital neutropenia: experience of the French SCN register. Bone Marrow Transplant 2005; 35: 45–50.
Donadieu J, Stephan JL, Blanche S, Cavazzana-Calvo M, Baruchel A, Herbelin C et al. Treatment of juvenile chronic myelomonocytic leukemia by allogeneic bone marrow transplantation. Bone Marrow Transplant 1994; 13: 777–782.
Dror Y, Freedman MH . Shwachman–Diamond syndrome marrow cells show abnormally increased apoptosis mediated through the Fas pathway. Blood 2001; 97: 3011–3016.
Thornley I, Dror Y, Sung L, Wynn RF, Freedman MH . Abnormal telomere shortening in leucocytes of children with Shwachman–Diamond syndrome. Br J Haematol 2002; 117: 189–192.
Sauer M, Zeidler C, Meissner B, Rehe K, Hanke A, Welte K et al. Substitution of cyclophosphamide and busulfan by fludarabine, treosulfan and melphalan in a preparative regimen for children and adolescents with Shwachman–Diamond syndrome. Bone Marrow Transplant 2007; 39: 143–147.
Kuijpers TW, Alders M, Tool AT, Mellink C, Roos D, Hennekam RC . Hematologic abnormalities in Shwachman Diamond syndrome: lack of genotype–phenotype relationship. Blood 2005; 106: 356–361.
Mäkitie O, Ellis L, Durie PR, Morrison JA, Sochett EB, Rommens JM et al. Skeletal phenotype in patients with Shwachman–Diamond syndrome and mutations in SBDS. Clin Genet 2004; 65: 101–112.
Kawakami T, Mitsui T, Kanai M, Shirahata E, Sendo D, Kanno M et al. Genetic analysis of Shwachman–Diamond syndrome: phenotypic heterogeneity in patients carrying identical SBDS mutations. Tohoku J Exp Med 2005; 206: 253–259.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bhatla, D., Davies, S., Shenoy, S. et al. Reduced-intensity conditioning is effective and safe for transplantation of patients with Shwachman–Diamond syndrome. Bone Marrow Transplant 42, 159–165 (2008). https://doi.org/10.1038/bmt.2008.151
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2008.151
Keywords
This article is cited by
-
Approach Toward Germline Predisposition Syndromes in Patients with Hematologic Malignancies
Current Hematologic Malignancy Reports (2022)
-
Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman–Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP-EBMT)
Bone Marrow Transplantation (2020)
-
First experience of hematopoietic stem cell transplantation treatment of Shwachman–Diamond syndrome using unaffected HLA–matched sibling donor produced through preimplantation HLA typing
Bone Marrow Transplantation (2017)
-
Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes
Bone Marrow Transplantation (2015)
-
Congenital neutropenia: diagnosis, molecular bases and patient management
Orphanet Journal of Rare Diseases (2011)